| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $44.1M | — | +6.5% |
| Cost of Revenue | $22.9M | — | +7.4% |
| Gross Profit | $21.3M | — | +5.4% |
| R&D Expense | $9.6M | — | -1.2% |
| SG&A Expense | $18.5M | — | +43.2% |
| Operating Income | -$18.5M | — | -23.3% |
| Income Tax | $1.5M | — | +997.8% |
| Net Income | -$18.9M | — | -65.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $65.7M | -27.7% | -31.1% |
| Accounts Receivable | $51.9M | -17.0% | -5.7% |
| Inventory | $49.8M | +2.8% | +9.8% |
| Current Assets | $379.3M | -3.2% | -0.3% |
| Total Assets | $449.1M | -2.7% | -6.9% |
| Current Liabilities | $80.9M | +4.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.7M | — | -2088.8% |
| Capital Expenditures | $2.2M | — | +155.4% |
| Investing Cash Flow | -$27.1M | — | -386.5% |
| Financing Cash Flow | $4.0M | — | +134.5% |
| Free Cash Flow | -$4.9M | — | -403.5% |
| +19.6% |
| Total Liabilities | $121.5M | +1.4% | +18.0% |
| Stockholders' Equity | $327.6M | -4.1% | -13.7% |